Objective-To study the effects on myocardial ischaemia of 50 mg of atenolol, 20 mg of slow release nifedipine, and their fixed combination given 12 hourly.
beats/min respectively. The number of exercise tests rendered negative after each intervention was five for nifedipine, nine for atenolol, and 11 for the combination. Compared with the control the time to the start of myocardial ischaemia (1 mm ST segment depression) during exercise significantly increased by 3-2 (0-6) min after nifedipine, by 4-6 (0 4) min after atenolol, and by [4] [5] [6] (0 5) min after the combination; rate-pressure product (beats/min. mm Hg) at 1 mm ST segment depression increased by 2824 (970) after nifedipine but fell by 4436 (900) and 4501 (719) after atenolol and the combination. The weekly frequency of angina was reduced from a mean of five while taking nifedipine, to three while taking atenolol, and to two while taking the combination. The total ischaemic time during ambulatory monitoring was significantly reduced from 69 (17) min during control to 37-5 min during nifedipine, to 15-6 (5-5) min during atenolol, and to (2-7) min during the combination.
Conclusion-The undesirable effect ofa high basal heart rate induced by nifedipine was neutralised by its combination with atenolol. Whereas atenolol and the combination were equally efficacious in controiling exercise induced ischaemia, the combination was more effective in reducing total ischaemic burden.
(Br Heart J 1992;68: In most patients with chronic stable angina, both an increase in myocardial oxygen consumption and a decrease in myocardial blood flow contribute to the development of ischaemia, whether symptoms occur at rest or during exercise.' 2 3 Blockers relieve ischaemia primarily by decreasing myocardial oxygen demand, and calcium channel blockers do so by improving myocardial oxygen supply. By acting on these different determinants of myocardial ischaemia, the combination of both drugs could provide better control of myocardial ischaemia.
We have investigated the anti-ischaemic effects of a calcium antagonist (nifedipine) and a ,B blocker (atenolol) singly and in a fixed combination on symptoms, and exercise induced and ambulatory ischaemia.
Patients and methods Thirty patients were enrolled, but only 23 completed the study: 19 men and four women, aged 40 to 72 (mean 56-2) years, who had stable exertional angina of eight to 156 months duration (mean 56.2). The other seven patients were excluded at the end of the run in period because of a negative exercise test and were not included in the analysis. All patients had positive exercise tests for myocardial ischaemia () 1 mm horizontal or downsloping ST segment depression, measured 60 ms after the J point) and documented coronary artery disease (five patients with one vessel, 11 patients with two vessel and seven patients with three vessel disease). There had been no change in the frequency, duration, or severity of their angina in the three months before the study. Four patients had suffered a previous Q wave myocardial infarction (> six months) before the study. All patients had normal blood pressure, were in sinus rhythm, and had no evidence of heart failure, cardiomyopathy, or valvar heart disease. Compared with the control the resting heart rate was increased by 13 (7) beats/min with nifedipine (p < 0-001) but was reduced by 22 (7) beats/min by atenolol and 19 (7) by the combination (p < 0-001). Figure 4 gives the heart rate measured minute by minute during the exercise tests, and shows that nifedipine resulted in a higher heart rate throughout exercise when compared with control, atenolol, and the combination of atenolol and nifedipine. improving collateral blood flow to ischaemic regions.9 The systemic vasodilatory effect of nifedipine also acts to reduce myocardial consumption of oxygen but the peripheral action stimulates reflex action of the sympathetic nervous system.'0 The resulting increases in heart rate may reduce the antianginal effects of this drug" and account for our finding of only a small beneficial effect.
In our study, atenolol alone significantly increased the exercise time to 1 mm ST segment depression compared with nifedipine alone and made nine out of 23 exercise tests negative. This was achieved by a reduction of the heart rate at rest and during exercise (patients reached a mean maximum heart rate ofonly 100 beats/min after exercising for nearly 15 minutes) (fig 4) . Atenolol also reduced the total duration of ambulatory ischaemia, further than nifedipine, by 77% of the control value. It also had a beneficial effect on the number of anginal attacks when compared with nifedipine monotherapy. ,B Blockers are known to relieve ischaemia primarily by decreasing myocardial oxygen demand through inhibition of the rise in heart rate and blood pressure that accompanies submaximal and maximal exercise.'2 They have been shown in other studies to be effective in reducing ischaemia during ambulatory activities.'3 The fixed combination of atenolol and nifedipine produced effects during exercise testing similar to those found with atenolol alone, and also produced similar behaviour of the heart rate ( fig 4) .
In conclusion atenolol and its combination with sustained release nifedipine are equally efficacious in controlling that aspect of stable angina which is due to dynamic exercise alone. This effect is explained by the similar behaviour ofheart rate during exercise with both preparations. The additional benefit, however, of the combination on ambulatory ischaemia during unrestricted daily life is consistent with the effect of nifedipine on that component of chronic angina determined by variations in vasomotor tone. The potentially adverse effect of the high resting heart rate induced by nifedipine on the dynamic exercise component of angina is neutralised by its combination with atenolol.
